Cargando…
Targeted Next-Generation Sequencing of Cancer-Related Genes in a Norwegian Patient Cohort With Head and Neck Squamous Cell Carcinoma Reveals Novel Actionable Mutations and Correlations With Pathological Parameters
BACKGROUND: Targeted next-generation sequencing (NGS) is increasingly applied in clinical oncology to advance personalized treatment. Despite success in many other tumour types, use of targeted NGS panels for assisting diagnosis and treatment of head and neck squamous cell carcinomas (HNSCC) is stil...
Autores principales: | Dongre, Harsh N., Haave, Hilde, Fromreide, Siren, Erland, Fredrik A., Moe, Svein Erik Emblem, Dhayalan, Sophia Manueldas, Riis, Rasmus Kopperud, Sapkota, Dipak, Costea, Daniela Elena, Aarstad, Hans Jorgen, Vintermyr, Olav K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497964/ https://www.ncbi.nlm.nih.gov/pubmed/34631566 http://dx.doi.org/10.3389/fonc.2021.734134 |
Ejemplares similares
-
The TP53 Codon 72 Arginine Polymorphism Is Found with Increased TP53 Somatic Mutations in HPV(−) and in an Increased Percentage among HPV(+) Norwegian HNSCC Patients
por: Moe, Svein Erik, et al.
Publicado: (2023) -
Tumor Infiltration Levels of CD3, Foxp3 (+) Lymphocytes and CD68 Macrophages at Diagnosis Predict 5-Year Disease-Specific Survival in Patients with Oropharynx Squamous Cell Carcinoma
por: Ljokjel, Borghild, et al.
Publicado: (2022) -
Tumor HPV Status, Level of Regulatory T Cells and Macrophage Infiltration Predict up to 20-Year Non-Disease-Specific Survival in Oropharynx Squamous Cell Carcinoma Patients
por: Haave, Hilde, et al.
Publicado: (2022) -
The Acute Phase Reaction and Its Prognostic Impact in Patients with Head and Neck Squamous Cell Carcinoma: Single Biomarkers Including C-Reactive Protein Versus Biomarker Profiles
por: Aarstad, Helene Hersvik, et al.
Publicado: (2020) -
In Vitro-Stimulated IL-6 Monocyte Secretion and In Vivo Peripheral Blood T Lymphocyte Activation Uniquely Predicted 15-Year Survival in Patients with Head and Neck Squamous Cell Carcinoma
por: Aarstad, Helene Hersvik, et al.
Publicado: (2015)